Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Translational Vaccinology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9434
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel research and has various development programs on vaccine delivery and formulation. Intravacc’s research and development programs comprise global health, bacterial and viral vaccines, polio center, animal models and 3R research, and vaccine formulation and delivery. The organization conducts research in various areas such as bacterial vaccine technology, viral vaccine technology, novel vaccines and clinical immunology. The organization works in collaboration with pharmaceutical, biotechnology, governments and public institutions to develop novel vaccines. Intravacc is headquartered in Bilthoven, the Netherlands.

Institute for Translational Vaccinology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Licensing Agreements 15
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology – Key Competitors 18
Institute for Translational Vaccinology – Key Employees 19
Institute for Translational Vaccinology – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
May 04, 2017: Thijs Veerman CEO at Intravacc 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology, Key Competitors 18
Institute for Translational Vaccinology, Key Employees 19

List of Figures
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Calix Ltd (CXL):企業の財務・戦略的SWOT分析
    Calix Ltd (CXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Composites Horizons, Inc.:企業の戦略・SWOT・財務情報
    Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report Summary Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Millennium Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Millennium Pharmaceuticals Inc (Millennium), a subsidiary of Takeda Pharmaceutical Company Ltd is a biopharmaceutical company that undertakes research, development, and commercialization of drugs for treating cancer. The company’s product Velcade is used for the treatment of multiple myeloma …
  • Stein Mart, Inc.:企業の戦略・SWOT・財務情報
    Stein Mart, Inc. - Strategy, SWOT and Corporate Finance Report Summary Stein Mart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nippon Paper Industries Co., Ltd.:戦略・SWOT・企業財務分析
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Neptune Technologies & Bioressources Inc:企業のM&A・事業提携・投資動向
    Neptune Technologies & Bioressources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neptune Technologies & Bioressources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Gymboree Group, Inc.:企業の戦略的SWOT分析
    Gymboree Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-医療機器分野:企業M&A・提携分析
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC) is a technology transfer company that offers marketing the inventions and know-how generated by the University's researchers and students. The company’s products include exelon, doxil, cherry tomatoes and lo …
  • Bill Peach Group Limited:企業の戦略・SWOT・財務情報
    Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tobu Railway Co Ltd:戦略・SWOT・企業財務分析
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • InterContinental Hotels Group Plc:企業のM&A・事業提携・投資動向
    InterContinental Hotels Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's InterContinental Hotels Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • USV Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary USV Pvt Ltd (USV) is a healthcare company that offers pharmaceutical products. The company’s products include active pharmaceutical ingredients, biosimilars, injectables, ophthalmics, peptides and solid orals. Its biosimilars products comprise PEG-filgrastim, teriparatide, somatropin, filgra …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Boiron SA:企業の戦略・SWOT・財務情報
    Boiron SA - Strategy, SWOT and Corporate Finance Report Summary Boiron SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Toei Animation Co., Ltd. (4816):企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆